Min-Huei Hsu

Prof. Min-Huei Hsu

Graduate Institute of Data Science, College of Management, Taipei Medical University, Taipei 110301, Taiwan

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2025 in Journal of Medical Systems
Verified
Journal Article
Open access
PDF file
FSFahad Shahid
Fahad Shahid
MHMin-Huei Hsu
Min-Huei Hsu
YCYung-Chun Chang
Yung-Chun Chang
WJWen-Shan Jian
Wen-Shan Jian
Manually converting unstructured text pathology reports into structured pathology reports is very time-consuming and prone to errors. This study demonstrates the transformative potential of generative AI in automating the analysis of free-text pathology reports. Employing the ChatGPT Large Language Model within a Streamlit web application, we automated the extraction and structuring of information from 33 unstructured breast cancer pathology reports from Taipei Medical University Hospital. Achieving a 99.61% accuracy rate, the AI system notably reduced the processing time compared to traditional methods. This not only underscores the efficacy of AI in converting unstructured medical text into structured data but also highlights its potential to enhance the efficiency and reliability of medical text analysis. However, this study is limited to breast cancer pathology reports and was conducted using data obtained from hospitals associated with a single institution. In the future, we plan to expand the scope of this research to include pathology reports for other cancer types incrementally and conduct external validation to further substantiate the robustness and generalizability of the proposed system. Through this technological integration, we aimed to substantiate the capabilities of generative AI in improving both the speed and reliability of data processing. The outcomes of this study affirm that generative AI can significantly transform the handling of pathology reports, promising substantial advancements in biomedical research by facilitating the structured analysis of complex medical data.

25 July 2023 in Cancer Science
Verified
Journal Article
Open access
QNQuynh Thi Nhu Nguyen
Quynh Thi Nhu Nguyen
PNPhung-Anh Nguyen
Phung-Anh Nguyen
CWChun‐Jung Wang
Chun‐Jung Wang
PPPhan Thanh Phuc
Phan Thanh Phuc
RLRuo‐Kai Lin
Ruo‐Kai Lin
JHJason C. Hsu
Jason C. Hsu
The study used clinical data to develop a prediction model for breast cancer survival. Breast cancer prognostic factors were explored using machine learning techniques. We conducted a retrospective study using data from the Taipei Medical University Clinical Research Database, which contains electronic medical records from three affiliated hospitals in Taiwan. The study included female patients aged over 20 years who were diagnosed with primary breast cancer and had medical records in hospitals between January 1, 2009 and December 31, 2020. The data were divided into training and external testing datasets. Nine different machine learning algorithms were applied to develop the models. The performances of the algorithms were measured using the area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and F1‐score. A total of 3914 patients were included in the study. The highest AUC of 0.95 was observed with the artificial neural network model (accuracy, 0.90; sensitivity, 0.71; specificity, 0.73; PPV, 0.28; NPV, 0.94; and F1‐score, 0.37). Other models showed relatively high AUC, ranging from 0.75 to 0.83. According to the optimal model results, cancer stage, tumor size, diagnosis age, surgery, and body mass index were the most critical factors for predicting breast cancer survival. The study successfully established accurate 5‐year survival predictive models for breast cancer. Furthermore, the study found key factors that could affect breast cancer survival in Taiwanese women. Its results might be used as a reference for the clinical practice of breast cancer treatment.

12 November 2022 in Cancers
Verified
Journal Article
Open access
PDF file
JHJason C. Hsu
Jason C. Hsu
PNPhung-Anh Nguyen
Phung-Anh Nguyen
PPPhuc Thanh Phan
Phuc Thanh Phan
TLTsai-Chih Lo
Tsai-Chih Lo
MHMin-Huei Hsu
Min-Huei Hsu
CCCheng-Yu Chen
Cheng-Yu Chen
A well-established lung-cancer-survival-prediction model that relies on multiple data types, multiple novel machine-learning algorithms, and external testing is absent in the literature. This study aims to address this gap and determine the critical factors of lung cancer survival. We selected non-small-cell lung cancer patients from a retrospective dataset of the Taipei Medical University Clinical Research Database and Taiwan Cancer Registry between January 2008 and December 2018. All patients were monitored from the index date of cancer diagnosis until the event of death. Variables, including demographics, comorbidities, medications, laboratories, and patient gene tests, were used. Nine machine-learning algorithms with various modes were used. The performance of the algorithms was measured by the area under the receiver operating characteristic curve (AUC). In total, 3714 patients were included. The best performance of the artificial neural network (ANN) model was achieved when integrating all variables with the AUC, accuracy, precision, recall, and F1-score of 0.89, 0.82, 0.91, 0.75, and 0.65, respectively. The most important features were cancer stage, cancer size, age of diagnosis, smoking, drinking status, EGFR gene, and body mass index. Overall, the ANN model improved predictive performance when integrating different data types.

28 March 2019 in JMIR Medical Informatics
Verified
Journal Article
Open access
HWHsyien-Chia Wen
Hsyien-Chia Wen
WCWei-Pin Chang
Wei-Pin Chang
MHMin-Huei Hsu
Min-Huei Hsu
CHCheng-Hsun Ho
Cheng-Hsun Ho
Chi-Ming ChuChi-Ming Chu
Chi-Ming Chu
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The rapid aging of the Taiwanese population has led to high medical needs for the elderly and increasing medical costs in recent years. The integration of patient information through electronic health records (EHRs) to reduce unnecessary medications and tests and enhance the quality of care has currently become an important issue. Objective: Although electronic data interchanges among hospitals and clinics have been implemented for many years in Taiwan, the interoperability of EHRs has still not been assessed. Hence, in this study, we analyzed the efficiency of data exchanges and provide suggestions for future improvements. Methods: We obtained 30 months of uploaded and downloaded data of EHRs among hospitals and clinics from the EMR Exchange Center (EEC) of the Ministry of Health and Welfare (MOHW) from January 2015 to June 2017. The objects of this study consisted of 21 medical centers, 84 district hospitals, 290 area hospitals and 5520 clinics. The four exchange EHR forms examined were blood tests, medical images, discharge summaries, and outpatient medical records. We used MYSQL software to save our data and used phpMyAdmin which is a PHP program to manage the database and then analyzed the data using SPSS 19.0 statistical software. Results: The quarterly mean uploaded volume of EHRs among hospitals was 52,790,721 (standard deviation (SD): 580,643) records. The quarterly mean downloaded volume of EHRs among hospitals and clinics was 650,323 (SD: 215,099) records. The ratio of uploaded to downloaded EHRs was about 81:1. The total volume of EHRs was mainly downloaded by medical centers and clinics which accounted for 53.8% (mean: 318,717.80) and 45.4% (mean: 269,082.10), respectively, and the statistical test was significant among different hospital accreditation levels (F=7.63, p<0.001). A comparison of EHR download volumes among the six National Health Insurance (NHI) branches showed that the central NHI branch downloaded 11,366,431 records (21.53%) which was the highest, and the eastern branch downloaded 1,615,391 records (3.06%) which was the lowest, and the statistical test among the six NHI branches was significant (F=8.82, p<0.001). The download volumes of laboratory tests and outpatient medical records were 26,980,425 (50.3%) and 21,747,588 records (40.9%), respectively, and were much higher than medical images and discharge summaries, and the statistical test was also significant (F=17.72, p<0.001). Finally, the download times showed that the average for x-rays was 32.05 seconds which was the longest, and 9.92 seconds for electrocardiograms which was the shortest, but there was no statistically significant difference among download times for various medical images. Conclusions: After years of operation, the EEC has achieved the initial goal of EHR interoperability, and data exchanges are running quite stably in Taiwan. However, the meaningful use of EHRs among hospitals and clinics still needs further encouragement and promotion. We suggest that the government’s leading role and collective collaboration with healthcare organizations are important keys to providing effective health information exchanges. Clinical Trial: MOHW105-IM-I-114-000017 (Department of Health and Welfare)

Verified
Journal Article
Open access
PDF file
Md. Mohaimenul IslamMd. Mohaimenul Islam
Md. Mohaimenul Islam
TPTahmina Nasrin Poly
Tahmina Nasrin Poly
Belal AlsinglawiBelal Alsinglawi
Belal Alsinglawi
MLMing-Chin Lin
Ming-Chin Lin
MHMin-Huei Hsu
Min-Huei Hsu
YLYu-Chuan (Jack) Li
Yu-Chuan (Jack) Li
Artificial intelligence (AI) has shown immense potential to fight COVID-19 in many ways. This paper focuses primarily on AI’s role in managing COVID-19 using digital images, clinical and laboratory data analysis, and a summary of the most recent articles published last year. We surveyed the use of AI for COVID-19 detection, screening, diagnosis, the progression of severity, mortality, drug repurposing, and other tasks. We started with the technical overview of all models used to fight the COVID-19 pandemic and ended with a brief statement of the current state-of-the-art, limitations, and challenges.

1 January 2014 in Circulation Journal
Verified
Journal Article
Open access
PDF file
TYTsung-Lin Yang
Tsung-Lin Yang
TWTao-Cheng Wu
Tao-Cheng Wu
CHChin-Chou Huang
Chin-Chou Huang
PHPo-Hsun Huang
Po-Hsun Huang
CCChia-Min Chung
Chia-Min Chung
HLHSIN-BANG LEU
HSIN-BANG LEU
Background: Tamoxifen is used for breast cancer treatment and has been reported to be beneficial for the cardiovascular system, but it is unclear whether tamoxifen exhibits a favorable cardiovascular effect in Asian patients. Methods and Results: From January, 1998 to December, 2006, a breast cancer cohort study was conducted using the Taiwan National Health Insurance database. Patients were divided according to whether tamoxifen was used. Study endpoints were occurrence of acute myocardial infarction (AMI), ischemic or hemorrhagic stroke and total cardiovascular events. A total of 3,690 female subjects were enrolled (mean age 50.1±11.3), 2,056 of whom received tamoxifen and 1,634 did not. During a mean follow-up of 6.9 years, the tamoxifen group had a significantly lower incidence of AMI (0.15% vs. 0.67%, P=0.008), ischemic stroke (1.99% vs. 3.30%, P=0.008), hemorrhagic stroke (0.15% vs. 0.55%, P=0.029), and total cardiovascular events (2.24% vs. 4.16%, P<0.001) than the non-exposed group. After adjusting for comorbidities, tamoxifen was independently associated with a reduced risk of myocardial infarction (hazard ratio [HR] 0.22; 95% confidence interval [CI] 0.07–0.70, ischemic stroke (HR 0.52; 95% CI 0.35–0.78), hemorrhagic stroke (HR 0.25; 95% CI 0.07–0.92), and total cardiovascular events (HR 0.54; 95% CI 0.37–0.78). Conclusions: In Asian female breast cancer patients, tamoxifen use was associated with reduced risks of AMI, ischemic, hemorrhagic stroke and total cardiovascular events. (Circ J 2014; 78: 135–140)